Evidence map›Paper›PMID 29732897›Full record

ArticleAIDS research and human retroviruses2018

Shifting the HIV Paradigm from Care to Cure: Proceedings from the Caribbean Expert Summit in Barbados, August 2017.

R Clive Landis, E Akinola Abayomi, Brendan C Bain, Edward Greene, George Janossy, Patrice Joseph, Deanna Kerrigan, J Philip McCoy, Cesar Nunez, Maurice O'Gorman and 9 more

Open access · bronzeAbstract readConference Proceedings
In one paragraph

Article in AIDS research and human retroviruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 5 countries.

R Clive Landis1 Edmund Cohen Laboratory for Vascular Research, George Alleyne Chronic Disease Research Centre, The University of the West Indies , Bridgetown, Barbados .
E Akinola Abayomi3 Division of Haematopathology, Faculty of Medicine, Tygerberg Academic Hospital, Stellenbosch University , Cape Town, South Africa .
Brendan C Bain4 Department of Medicine, University Hospital of the West Indies , Mona, Jamaica .
Edward Greene5 Office of the UN Secretary General , United Nations, New York, New York.
George Janossy6 Department of Immunology, University College Medical School, University College , London, United Kingdom .
Patrice Joseph7 Groupe Haïtien Etude pour le Sarcome de Kaposi et les Infections Opportunistes (GHESKIO) , Port-au-Prince, Haiti .
Deanna Kerrigan8 Department of Health, Behavior and Society, The Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University , Baltimore, Maryland.
J Philip McCoy9 National Heart, Lung, and Blood Institute, National Institutes of Health , Bethesda, Maryland.
Cesar Nunez10 UNAIDS Latin American and Caribbean Regional Support Team , Panama City, Panama .
Maurice O'Gorman11 Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Keck School of Medicine, University of Southern California , Los Angeles, California.
Alexander Pastoors12 Dutch Association of PLHIV , Amsterdam, the Netherlands .
Bharat S Parekh13 Division of Global HIV and TB, Centers for Disease Control and Prevention , Atlanta, Georgia .
Kim R Quimby1 Edmund Cohen Laboratory for Vascular Research, George Alleyne Chronic Disease Research Centre, The University of the West Indies , Bridgetown, Barbados .
Thomas C Quinn14 National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, Maryland.
Kevin R Robertson15 Department of Neurology, University of North Carolina , Chapel Hill, North Carolina.
Réjean Thomas16 Clinique médicale l'Actuel , Montreal, Canada .
Eric van Gorp17 Department of Viroscience, Erasmus Medical Centre , Rotterdam, the Netherlands .
Sten H Vermund18 Yale School of Public Health , New Haven, Connecticut.
Valerie Wilson19 Caribbean Med Labs Foundation , Port of Spain , Trinidad.
National Institutes of Health · USUniversity of the West Indies · BBCenters for Disease Control and Prevention · USErasmus University Rotterdam · NLGheskio Centers · HTNederlandse Vereniging voor Kindergeneeskunde · NLUniversity Hospital of the West Indies · JMUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · USYale New Haven Health System · US

Funding

Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI E. Jennifer Edelman · 2001 to 2026
$48.5M
Flow Cytometry Core FacilityZICHL005905 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI DAGUR, PRADEEP · 2009 to 2025
$32.3M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
NIMH NIH HHS P30 MH062294
6 · The paper itself

Abstract

The CCAS EXPERT SUMMIT convened an array of international experts in Barbados on August 27-31, 2017 under the theme "From Care to Cure-Shifting the HIV Paradigm." The Caribbean Cytometry & Analytical Society (CCAS) partnered with the Joint United Nations Programme on HIV/AIDS (UNAIDS) to deliver a program that reviewed the advances in antiretroviral therapy and the public health benefits accruing from treatment as prevention. Particular emphasis was placed on reexamining stigma and discrimination through a critical appraisal of whether public health messaging and advocacy had kept pace with the advances in medicine. Persistent fear of HIV driving discriminatory behavior was widely reported in different regions and sectors, including the healthcare profession itself; continued fear of the disease was starkly misaligned with the successes of new medical treatments and progress toward the UNAIDS 90-90-90 targets. The summit therefore adopted the mantra "Test-Treat-Defeat" to help engage with the public in a spirit of optimism aimed at creating a more conducive environment for persons to be tested and treated and, thereby, help reduce HIV disease and stigma at the individual and community levels.

Indexed as

Disease ManagementAnti-Retroviral AgentsBarbadosChemopreventionDisease Transmission, InfectiousFemaleHIV InfectionsHumansMaleSocieties, ScientificAnti-Retroviral AgentscureHIVmonitoringpreventionstigmatreatment

Identifiers

PMID29732897
PMCPMC6053839
OpenAlexW2802609897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.